03:39 AM EDT, 07/30/2025 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) reported fiscal Q1 core earnings Wednesday of 151 Japanese yen ($1.02) per diluted share, down from 176 yen a year earlier.

Three analysts polled by FactSet expected 153.8 yen.

Revenue for the quarter ended June 30 was 1.11 billion yen, compared with 1.21 billion yen a year earlier.

Analysts surveyed by FactSet expected 1.17 billion yen.

For fiscal 2025, the company reiterated its core EPS guidance of 485 yen. Analysts surveyed by FactSet expect 486.2 yen. Revenue for the fiscal year is projected to be 4.53 billion yen. Analysts polled by FactSet expect 4.56 billion yen.